Amicus Therapeutics (NASDAQ:FOLD) reported quarterly sales of $88.10 million which beat the analyst consensus estimate of $86.29 million by 2.09 percent. This is a 7.23 percent increase over sales of $82.15 million the same period last year.
Elon Musk Wants Out Of Twitter Deal Due To Lack Of Information: $44B Buyout Off The Table
In a breaking update, Elon Musk has backed out of his deal to buy Twitter, Inc (NYSE: TWTR) for $44 billion.
